Abstract
Mass spectrometry (MS) is a technique that can identify analytes on the basis of mass-to-charge (m/z) ratio. Although this technique has been used in research and specialized clinical laboratories for decades, however, in recent years, MS has been increasingly used in routine clinical laboratories. MS, especially when coupled to gas chromatography or liquid chromatography, provides very specific and often sensitive analysis of many analytes. Other advantages of MS include simultaneous analysis of multiple analytes (>100) and generally without need for specialized reagents. Commonly measured analytes by MS include drugs, hormones, and proteins.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hammett-Stabler CA, Garg U (2010) The evolution of mass spectrometry in the clinical laboratory. Methods Mol Biol 603:1–7
Strathmann FG, Hoofnagle AN (2011) Current and future applications of mass spectrometry to the clinical laboratory. Am J Clin Pathol 136:609–616
Pagotto U, Fanelli F, Pasquali R (2013) Insights into tandem mass spectrometry for the laboratory endocrinology. Rev Endocr Metab Disord 14:141
Vogeser M, Parhofer KG (2007) Liquid chromatography tandem-mass spectrometry (LC-MS/MS)--technique and applications in endocrinology. Exp Clin Endocrinol Diabetes 115:559–570
Soldin SJ, Soldin OP (2009) Steroid hormone analysis by tandem mass spectrometry. Clin Chem 55:1061–1066
Albrecht L, Styne D (2007) Laboratory testing of gonadal steroids in children. Pediatr Endocrinol Rev 5(Suppl 1):599–607
Handelsman DJ, Wartofsky L (2013) Requirement for mass spectrometry sex steroid assays in the Journal of Clinical Endocrinology and Metabolism. J Clin Endocrinol Metab 98:3971–3973
Garg U, Dasouki M (2006) Expanded newborn screening of inherited metabolic disorders by tandem mass spectrometry: clinical and laboratory aspects. Clin Biochem 39:315–332
Jones PM, Bennett MJ (2002) The changing face of newborn screening: diagnosis of inborn errors of metabolism by tandem mass spectrometry. Clin Chim Acta 324:121–128
Jimenez CR Verheul HM (2014) Mass spectrometry-based proteomics: from cancer biology to protein biomarkers, drug targets, and clinical applications. Am Soc Clin Oncol Educ Book e504–10
Li Y, Song X, Zhao X, Zou L, Xu G (2014) Serum metabolic profiling study of lung cancer using ultra high performance liquid chromatography/quadrupole time-of-flight mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 966:147–153
Whiteaker JR (2010) The increasing role of mass spectrometry in quantitative clinical proteomics. Clin Chem 56:1373–1374
Ho YP, Reddy PM (2011) Advances in mass spectrometry for the identification of pathogens. Mass Spectrom Rev 30:1203–1224
Lagace-Wiens P (2015) Matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF/MS)-based identification of pathogens from positive blood culture bottles. Methods Mol Biol 1237:47–55
Luan J, Yuan J, Li X, Jin S, Yu L, Liao M, Zhang H, Xu C, He Q, Wen B et al (2009) Multiplex detection of 60 hepatitis B virus variants by maldi-tof mass spectrometry. Clin Chem 55:1503–1509
Kriegsmann J, Kriegsmann M, Casadonte R (2014) MALDI TOF imaging mass spectrometry in clinical pathology: a valuable tool for cancer diagnostics (Review). Int J Oncol 46:893–906
Clarke W, Rhea JM, Molinaro R (2013) Challenges in implementing clinical liquid chromatography-tandem mass spectrometry methods--the light at the end of the tunnel. J Mass Spectrom 48:755–767
Roux A, Lison D, Junot C, Heilier JF (2011) Applications of liquid chromatography coupled to mass spectrometry-based metabolomics in clinical chemistry and toxicology: a review. Clin Biochem 44:119–135
Wu AH, French D (2013) Implementation of liquid chromatography/mass spectrometry into the clinical laboratory. Clin Chim Acta 420:4–10
Armbruster DA, Overcash DR, Reyes J (2014) Clinical chemistry laboratory automation in the 21st century - Amat Victoria curam (victory loves careful preparation). Clin Biochem Rev 35:143–153
Vogeser M, Kirchhoff F (2011) Progress in automation of LC-MS in laboratory medicine. Clin Biochem 44:4–13
Vogeser M, Seger C (2010) Pitfalls associated with the use of liquid chromatography-tandem mass spectrometry in the clinical laboratory. Clin Chem 56:1234–1244
Carvalho VM (2012) The coming of age of liquid chromatography coupled to tandem mass spectrometry in the endocrinology laboratory. J Chromatogr B Analyt Technol Biomed Life Sci 883–884:50–58
Himmelsbach M (2012) 10 years of MS instrumental developments--impact on LC-MS/MS in clinical chemistry. J Chromatogr B Analyt Technol Biomed Life Sci 883–884:3–17
CLSI (2014) Liquid chromatography-mass spectrometry methods; Approved guideline. Document C62-A, vol 62-A. CLSI, Wayne, PA
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Garg, U., Zhang, Y.V. (2016). Mass Spectrometry in Clinical Laboratory: Applications in Biomolecular Analysis. In: Garg, U. (eds) Clinical Applications of Mass Spectrometry in Biomolecular Analysis. Methods in Molecular Biology, vol 1378. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3182-8_1
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3182-8_1
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3181-1
Online ISBN: 978-1-4939-3182-8
eBook Packages: Springer Protocols